Abstract
Tuberculosis (TB) continues to generate an overwhelming effect on the lives of many people, leading to an alarming number of 1.4 million deaths per year and the only available vaccine currently, Mycobacterium bovis bacille Calmette-Guérin (BCG), have shown disagreements about its protective effect. For several decades vaccines candidates have been developed against TB, some even reaching …